Antonino Farulla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Antonino Farulla has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Carlo Alboni
Univ Modena & reggio emilia, Unit Minimally Invas & Robot Gynecol Surg, AOU Policlin Modena, Via Pozzo 71, I-41125 Modena, Italy
5 shared publicationsFabio Facchinetti
Minimally Invasive and Robotic Gynecologic Surgery Unit, Policlinico di Modena University of Modena and Reggio Emilia, Modena, Italy; Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy
2 shared publicationsLudovica Camacho Mattos
Univ Hosp Modena, Unit Minimally Invas & Robot Gynecol Surg, Modena, Italy
2 shared publicationsAlfredo Ercoli
Department of Human Pathology of the Adult and of the Childhood "Gaetano Barresi", Università di Messina, Messina, Italy
1 shared publication- Ambra Cassar Scalia
Department of Radiology, Azienda Ospedaliero-Universitaria Policlinico di Modena, Italy
1 shared publication - Annarita Pecchi
Department of Radiology, University of Modena and Reggio Emilia, Modena, Italy
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
The ultrasound-based #Enzian classification as a prognostic tool for fertility in women with endometriosis: a real-world cohort study
PurposeTo evaluate whether the ultrasound-based #Enzian classification provides prognostic information on fertility in women with endometriosis, and whether it can be used as a tool for individualized counselling regarding the likelihood of spontaneous and ART-assisted conception.MethodsWe conducted a retrospective cohort study at a tertiary referral center (2018-2023). From 723 women with endometriosis, 78 met the inclusion criteria: ultrasound-confirmed disease, active desire for pregnancy, and no hormonal therapy or surgery at baseline. Patients were followed for a median of 48 months (range 14-60). Clinical, sonographic, reproductive, and surgical data were collected. Associations between #Enzian compartments and pregnancy outcomes were analysed using Cox regression adjusted for male factor infertility.ResultsFifty-five of 78 women (70.5%) achieved pregnancy, with a live birth (LB) rate of 44.9% and a median time to pregnancy (TTP) of 24 months, confirming subfertility in this population. Among them, 36 conceived spontaneously and 19 through ART. During follow-up, 36 women (46.2%) underwent surgery after failed spontaneous attempts and worsening symptoms; 19 conceived postoperatively, resulting in 15 LB, with a median TTP of 36 months. Adenomyosis (F.A) and right tubo-ovarian adhesions (T.right) were significantly associated with reduced pregnancy rates (HR 0.27 and 0.74, respectively) and both negatively influenced ART success (HR for F.A 0.25). Compartment A (rectovaginal space and vagina) involvement was linked to significantly longer TTP (+10.2 months, p=0.020).ConclusionWomen with endometriosis are subfertile, with prolonged TTP and reduced LB rates. The ultrasound-based #Enzian classification provides compartment-specific prognostic information, supporting its role as a non-invasive tool to refine fertility counselling and guide clinical management.
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe ultrasound-based #Enzian classification as a prognostic tool for fertility in women with endometriosis: a real-world cohort study
PurposeTo evaluate whether the ultrasound-based #Enzian classification provides prognostic information on fertility in women with endometriosis, and whether it can be used as a tool for individualized counselling regarding the likelihood of spontaneous and ART-assisted conception.MethodsWe conducted a retrospective cohort study at a tertiary referral center (2018-2023). From 723 women with endometriosis, 78 met the inclusion criteria: ultrasound-confirmed disease, active desire for pregnancy, and no hormonal therapy or surgery at baseline. Patients were followed for a median of 48 months (range 14-60). Clinical, sonographic, reproductive, and surgical data were collected. Associations between #Enzian compartments and pregnancy outcomes were analysed using Cox regression adjusted for male factor infertility.ResultsFifty-five of 78 women (70.5%) achieved pregnancy, with a live birth (LB) rate of 44.9% and a median time to pregnancy (TTP) of 24 months, confirming subfertility in this population. Among them, 36 conceived spontaneously and 19 through ART. During follow-up, 36 women (46.2%) underwent surgery after failed spontaneous attempts and worsening symptoms; 19 conceived postoperatively, resulting in 15 LB, with a median TTP of 36 months. Adenomyosis (F.A) and right tubo-ovarian adhesions (T.right) were significantly associated with reduced pregnancy rates (HR 0.27 and 0.74, respectively) and both negatively influenced ART success (HR for F.A 0.25). Compartment A (rectovaginal space and vagina) involvement was linked to significantly longer TTP (+10.2 months, p=0.020).ConclusionWomen with endometriosis are subfertile, with prolonged TTP and reduced LB rates. The ultrasound-based #Enzian classification provides compartment-specific prognostic information, supporting its role as a non-invasive tool to refine fertility counselling and guide clinical management.
- 1 January 2025
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 76 (6)
Endometriosis and risk factors in pregnancy, labor and delivery: a case-control study
Article: Endometriosis and risk factors in pregnancy, labor and delivery: a case-control study - Minerva Obstetrics and Gynecology 2024 Nov 08 - Minerva Medica - Journals
- 1 January 2025
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 76 (6)
Endometriosis and risk factors in pregnancy, labor and delivery: a case-control study
Article: Endometriosis and risk factors in pregnancy, labor and delivery: a case-control study - Minerva Obstetrics and Gynecology 2024 Nov 08 - Minerva Medica - Journals
- 1 November 2023
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 76 (3) , 264-271
Effects of osteopathic manipulative therapy on recurrent pelvic pain and dyspareunia in women after surgery for endometriosis: a retrospective study
Article: Effects of osteopathic manipulative therapy on recurrent pelvic pain and dyspareunia in women after surgery for endometriosis: a retrospective study - Minerva Obstetrics and Gynecology 2023 Nov 23 - Minerva Medica - Journals
- 1 November 2023
- Published by Edizioni Minerva Medica in Minerva Obstetrics and Gynecology
- Vol. 76 (3) , 264-271
Effects of osteopathic manipulative therapy on recurrent pelvic pain and dyspareunia in women after surgery for endometriosis: a retrospective study
Article: Effects of osteopathic manipulative therapy on recurrent pelvic pain and dyspareunia in women after surgery for endometriosis: a retrospective study - Minerva Obstetrics and Gynecology 2023 Nov 23 - Minerva Medica - Journals
- Open Access
- 3 January 2022
- Published by Springer Nature in Research Square
Impact on Quality of Life of Laparoscopic Nerve-sparing Radical Treatment of Parametrial Deep Infiltrating Endometriosis (Postoperative Pain Assessment and Functional Outcomes)
Objective: Complete eradication of parametrial nodules of Deep Infiltrating Endometriosis (DIE) is associated with a high risk of iatrogenic nerves damage and pelvic organs dysfunction. The aim of this study is to evaluate via validated questionnaires the effect of laparoscopic excision of parametrial DIE on quality of life as first outcome and on pain symptoms and post- operative voiding function (bladder and rectal) as secondary outcome.Study design: All patients undergoing laparoscopic excision of posterior or lateral parametrial DIE by a single expert surgeon between January 2013 and March 2017 were included in the study. A nerve-sparing approach was adopted in all patients. Quality of life (QoL) and Functional outcomes were evaluated using validated questionnaires (EHP-30 for the health profile, NBD score for intestinal function, ICIQ-FLUTS for urinary function), administered preoperatively and after surgery. Pain scores were collected before and after surgery using Visual Analogue Scale (VAS).Results: During the study period a total of fifty-nine patients met the inclusion criteria. Fifty-one patients agreed to fill out questionnaires for post-operative outcomes. EHP-30 scores had a significant improvement in all the domains analyzed even in the relationship with children and fertility module despite to the small number of patients answering those questions. No differences were found in terms of urinary function between pre and post-operative questionnaires (ICIQ-FLUTS). Bowel function improved in patients’ subjective perception. The NBD score showed that intestinal dysfunction related only to constipation and was reported as very minor by 76.4% of patients, minor by 11.8%, moderate by 5.9% by and severe by 5.95% of patients. Pain symptoms (VAS score) decreased significantly after surgery with the exception of chronic pelvic pain. (p value < 0,05). Conclusions: Laparoscopic nerve-sparing radical excision of parametrial DIE is safe and effective when performed by an expert surgical equipe. This approach can favorably impact on patients QoL. Moreover, it has proved to result in pain score and voiding function improvements.
- 3 January 2022
- Published by Springer Nature in Research Square
Open AccessImpact on Quality of Life of Laparoscopic Nerve-sparing Radical Treatment of Parametrial Deep Infiltrating Endometriosis (Postoperative Pain Assessment and Functional Outcomes)
Objective: Complete eradication of parametrial nodules of Deep Infiltrating Endometriosis (DIE) is associated with a high risk of iatrogenic nerves damage and pelvic organs dysfunction. The aim of this study is to evaluate via validated questionnaires the effect of laparoscopic excision of parametrial DIE on quality of life as first outcome and on pain symptoms and post- operative voiding function (bladder and rectal) as secondary outcome.Study design: All patients undergoing laparoscopic excision of posterior or lateral parametrial DIE by a single expert surgeon between January 2013 and March 2017 were included in the study. A nerve-sparing approach was adopted in all patients. Quality of life (QoL) and Functional outcomes were evaluated using validated questionnaires (EHP-30 for the health profile, NBD score for intestinal function, ICIQ-FLUTS for urinary function), administered preoperatively and after surgery. Pain scores were collected before and after surgery using Visual Analogue Scale (VAS).Results: During the study period a total of fifty-nine patients met the inclusion criteria. Fifty-one patients agreed to fill out questionnaires for post-operative outcomes. EHP-30 scores had a significant improvement in all the domains analyzed even in the relationship with children and fertility module despite to the small number of patients answering those questions. No differences were found in terms of urinary function between pre and post-operative questionnaires (ICIQ-FLUTS). Bowel function improved in patients’ subjective perception. The NBD score showed that intestinal dysfunction related only to constipation and was reported as very minor by 76.4% of patients, minor by 11.8%, moderate by 5.9% by and severe by 5.95% of patients. Pain symptoms (VAS score) decreased significantly after surgery with the exception of chronic pelvic pain. (p value < 0,05). Conclusions: Laparoscopic nerve-sparing radical excision of parametrial DIE is safe and effective when performed by an expert surgical equipe. This approach can favorably impact on patients QoL. Moreover, it has proved to result in pain score and voiding function improvements.
- 1 January 2021
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 28 (1) , 18-19
Robot-Assisted Nerve-sparing Resection of Bilateral Parametrial Deep Infiltrating Endometriosis
- 1 January 2021
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 28 (1) , 18-19
Robot-Assisted Nerve-sparing Resection of Bilateral Parametrial Deep Infiltrating Endometriosis
- Open Access
- 25 September 2018
- Published by EduRad in Journal of Radiology Case Reports
- Vol. 12 (9) , 21-30
Imaging features of uterine and ovarian fibromatosis in Nevoid Basal Cell Carcinoma Syndrome
Gorlin-Goltz Syndrome also known as Nevoid Basal Cell Carcinoma Syndrome is an autosomal dominant multisystem disorder. It is characterized by basal cell carcinomas, odontogenic keratocysts, skeletal abnormalities and in a minority of female patients bilateral calcified ovarian fibromas. It is challenging to radiologically assess ovarian fibromas as they have similar imaging patterns to some malignant ovarian lesions. However, it is vitally important to differentiate between benign and malignant lesions to determine patients' suitability for fertility-sparing surgery. This report describes a case of a 25 year-old patient with Gorlin-Goltz Syndrome and bilateral ovarian fibromas.
- 25 September 2018
- Published by EduRad in Journal of Radiology Case Reports
- Vol. 12 (9) , 21-30
Open AccessImaging features of uterine and ovarian fibromatosis in Nevoid Basal Cell Carcinoma Syndrome
Gorlin-Goltz Syndrome also known as Nevoid Basal Cell Carcinoma Syndrome is an autosomal dominant multisystem disorder. It is characterized by basal cell carcinomas, odontogenic keratocysts, skeletal abnormalities and in a minority of female patients bilateral calcified ovarian fibromas. It is challenging to radiologically assess ovarian fibromas as they have similar imaging patterns to some malignant ovarian lesions. However, it is vitally important to differentiate between benign and malignant lesions to determine patients' suitability for fertility-sparing surgery. This report describes a case of a 25 year-old patient with Gorlin-Goltz Syndrome and bilateral ovarian fibromas.
- 26 March 2018
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 19 (7) , 677-686
Levonorgestrel-releasing intra-uterine systems as female contraceptives
The availability and use of long-acting reversible contraceptives (LARCs), such as levonorgestrel intrauterine systems (LNG-IUSs), have increased in recent times. The authors provide a narrative review of the LNG-IUSs currently available worldwide as female contraceptives (LNG-IUS 13.5, 19.5 and 52 mg). Specific features of the devices and their parameters of efficacy and tolerability were considered as outcomes. The one-handed 3.8-mm-diameter inserter of LNG-IUS 13.5 mg and 19.5 mg may be particularly suitable in nulliparous women. While LNG-IUSs 13.5, 19.5 mg and LNG 52 mg should be used by women simply looking for an effective contraceptive method for up to 3, 4 or 5 years, LNG-IUS 52 mg has also been approved for the treatment of heavy menstrual bleeding and endometrial protection during hormone replacement therapy. LNG-IUS 52 mg is ideal for women who are experiencing a certain hyperestrogenic hormonal environment, with heavy menstrual bleeding due to hormonal imbalances, adenomyosis or fibroids, in the case of symptomatic endometriosis or for endometrial protection during hormone estrogenic replacement therapy in non-hysterectomized women.
- 26 March 2018
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 19 (7) , 677-686
Levonorgestrel-releasing intra-uterine systems as female contraceptives
The availability and use of long-acting reversible contraceptives (LARCs), such as levonorgestrel intrauterine systems (LNG-IUSs), have increased in recent times. The authors provide a narrative review of the LNG-IUSs currently available worldwide as female contraceptives (LNG-IUS 13.5, 19.5 and 52 mg). Specific features of the devices and their parameters of efficacy and tolerability were considered as outcomes. The one-handed 3.8-mm-diameter inserter of LNG-IUS 13.5 mg and 19.5 mg may be particularly suitable in nulliparous women. While LNG-IUSs 13.5, 19.5 mg and LNG 52 mg should be used by women simply looking for an effective contraceptive method for up to 3, 4 or 5 years, LNG-IUS 52 mg has also been approved for the treatment of heavy menstrual bleeding and endometrial protection during hormone replacement therapy. LNG-IUS 52 mg is ideal for women who are experiencing a certain hyperestrogenic hormonal environment, with heavy menstrual bleeding due to hormonal imbalances, adenomyosis or fibroids, in the case of symptomatic endometriosis or for endometrial protection during hormone estrogenic replacement therapy in non-hysterectomized women.